IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 105 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,942,926 | +232.1% | 249,382 | +283.7% | 0.01% | +250.0% |
| Q2 2023 | $3,897,400 | +43070.1% | 65,000 | -64.4% | 0.00% | -60.0% |
| Q1 2023 | $9,028 | -60.0% | 182,603 | -53.9% | 0.01% | -61.5% |
| Q4 2022 | $22,584 | -99.7% | 395,728 | +153.4% | 0.01% | +225.0% |
| Q3 2022 | $7,331,000 | +268.8% | 156,182 | +193.1% | 0.00% | +300.0% |
| Q2 2022 | $1,988,000 | +105.2% | 53,278 | +64.4% | 0.00% | 0.0% |
| Q1 2022 | $969,000 | -72.1% | 32,400 | -65.5% | 0.00% | -50.0% |
| Q3 2021 | $3,478,000 | -13.6% | 93,812 | -9.0% | 0.00% | 0.0% |
| Q2 2021 | $4,027,000 | -53.6% | 103,121 | -49.4% | 0.00% | -66.7% |
| Q1 2021 | $8,670,000 | – | 203,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $34,592,303 | 27.53% |
| RTW INVESTMENTS, LP | 6,029,633 | $361,536,795 | 6.88% |
| Paradigm Biocapital Advisors LP | 1,270,124 | $76,156,635 | 5.88% |
| Rock Springs Capital Management LP | 3,028,410 | $181,583,464 | 4.32% |
| Logos Global Management LP | 500,000 | $29,980,000 | 4.08% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $24,319,776 | 3.58% |
| GREAT POINT PARTNERS LLC | 297,082 | $17,813,037 | 3.49% |
| Eschler Asset Management LLP | 34,000 | $2,038,640 | 2.89% |
| COWEN AND COMPANY, LLC | 460,036 | $27,583,758 | 2.29% |
| HighVista Strategies LLC | 44,094 | $2,643,876 | 1.21% |